RxDoctor Payments Data

Joseph Brown, DPM

Podiatrist · Seaford, DENPI 1245253491

Payments from drug & device makers

What this record shows

21 manufacturers reported payments, led by Orthofix Medical, Inc. at 25.7% of the total. That places this record below the midpoint for podiatrist clinicians in DE, where the typical reported total is $1,099.

$1,600in general payments, 2019–2025

Across 48 payments — averaging $33.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orthofix Medical, Inc.$411
  • Stryker$315
  • Organogenesis Inc.$141
  • Smith+Nephew$132
  • Johnson & Johnson$130
  • Melinta Therapeutics, LLC$79
  • plus $392 from 15 others

What the payments were for

  • Travel & lodging$68843%
  • Food & beverage$91257%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,600 in reported general payments places this provider in the 50th percentile of 37 podiatrist providers in Delaware.

See all podiatrist providers in Delaware

Medicare billing

Part B allowed, 2024
$260,428
Medicare patients
841
Services billed
4,102

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole138$3,849
Ciclopirox29$1,100
Naproxen22$515
Clotrimazole11$336
Clindamycin Hcl17$251

Paid to pharmacies, not to this prescriber.

Other podiatrist in Seaford

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →